{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":1,"sponsored":0,"items":[{"id":"n_rccnpjj5twyechhicfea","seq":1422593,"kind":"article","title":"Merck stops making Recarbrio, highlighting tricky landscape for new antibiotics","url":"https://www.healio.com/news/infectious-disease/20261002/merck-stops-making-recarbrio-highlighting-tricky-landscape-for-new-antibiotics","summary":"Merck has decided to discontinue production of a combination antibiotic used in hospitals to target life-threatening infections resistant to other medications. The drug company told Healio the decision to pull Recarbrio off the U.S. market was part of an “ongoing portfolio review” and not based on product safety or quality issues. It expected the remaining inventory to be depleted by the end of last month. “We understand that Recarbrio has been an important option for…","published":"2026-10-02T19:39:15Z","seen":"2026-10-02T20:17:22Z","lang":"en","source":{"id":"kite-healio-com-23151b","name":"healio.com","domain":"healio.com"},"via":"kite-healio-com-23151b","topics":["medicine"],"authors":["Anthony Stitt"],"entities":[{"id":"Q96472579","name":"Merck","type":"org"},{"id":"Q65648491","name":"imipenem/cilastatin/relebactam","type":"other"}],"mentions":2,"story":"st_3vrothd66ymdjmtc55xq","category":"economy-business","category_p":0.49,"sentiment":"neutral","tone":-0.38,"political":0.18}]}